key: cord-1018415-lu7uhtzt authors: Fu, Shuai; Cheng, Rongrong; Deng, Zixin; Liu, Tiangang title: Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS date: 2021-01-30 journal: J Pharm Anal DOI: 10.1016/j.jpha.2021.01.004 sha: d38062b04f9f7d267494940e94c52ea54d1a2ea2 doc_id: 1018415 cord_uid: lu7uhtzt The Lianhua Qingwen (LHQW) capsule is a popular traditional Chinese medicine for the treatment of viral respiratory diseases. In particular, it has been recently prescribed to treat infections caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, due to its complex composition, little attention has been directed toward the analysis of chemical constituents present in the LHQW capsule. This study presents a reliable and comprehensive approach to characterizing the chemical constituents present in LHQW by high-performance liquid chromatography-Q Exactive-Orbitrap mass spectrometry (HPLC-Q Exactive-Orbitrap-MS) coupled with gas chromatography-mass spectrometry (GC-MS). An automated library alignment method with a high mass accuracy (within 5 ppm) was used for the rapid identification of compounds. A total of 104 compounds, consisting of alkaloids, flavonoids, phenols, phenolic acids, phenylpropanoids, quinones, terpenoids, and other phytochemicals, were successfully characterized. In addition, the fragmentation pathways and characteristic fragments of some representative compounds were elucidated. GC-MS analysis was conducted to characterize the volatile compounds present in LHQW. In total, 17 compounds were putatively characterized by comparing the acquired data with that from the NIST library. The major constituent was menthol, and all the other compounds were terpenoids. This is the first comprehensive report on the identification of the major chemical constituents present in the LHQW capsule by HPLC-Q Exactive-Orbitrap-MS, coupled with GC-MS, and the results of this study can be used for the quality control and standardization of LHQW capsules. Lianhua Qingwen capsule (LHQW), produced by Yiling Pharmaceutical Co., Ltd. (Shijiazhuang, China), is a patented traditional Chinese medicine (TCM). It was developed to treat patients infected with the severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) in China. LHQW is based on two TCM formulas, i.e., Maxing-Shigan-Tang and Yinqiao-San, which were originally mentioned in the classical Chinese books ShangHanLun and WenBingTiaoBian, respectively [1] . Both Maxing-Shigan-Tang and Yinqiao-San are prescribed to treat fever, inflammation, and seasonal influenza [2, 3] . LHQW is composed of 11 herbs [4] : Forsythiae Fructus, Lonicerae Japonicae Flos, Ephedrae Herba, Armeniacae Semen Amarum, Isatidis Radix, Dryopteridis Crassirhizomatis Rhizoma, Houttuyniae Herba, Pogostemonis Herba, Rhei Radix Et Rhizoma, Rhodiolae Crenulatae Radix Et Rhizoma and Glycyrrhizae Radix Et Rhizoma. In addition, it contains Gypsum Fibrosum, a mineral and menthol, extracted from Menthae Haplocalycis Herba. In China, LHQW has been widely used to treat the symptoms of respiratory diseases. Various reports have established the good anti-influenza activity of LHQW against H7N9 [1] and H1N1 [5] viruses. In particular, a randomized, double-blind, and positive clinical trial indicated that effectiveness of LHQW against the H1N1 virus is similar to that of Oseltamivir [5] . Another recent study has reported that LHQW is also effective against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [6] , the pathogen that causes the coronavirus disease . Thus, LHQW has been included as a representative TCM prescription in the Guideline for the Diagnosis and Treatment of COVID-19 Pneumonia issued by the National Heath Commission of the People's Republic of China [7] . However, the use of LHQW is limited to China. For LHQW to be globally accepted, its chemical composition and mechanism of action must be well understood. Thus, it is essential to determine the chemical composition of LHQW, which can further enable its quality control and standardization. Several analytical methods have been developed for the quality control of LHQW. For example, Zhang et al. [8] and Chen et al. [9] developed ultra-performance liquid chromatography (UPLC) fingerprinting methods for the quality control of LHQW. Qiao et al. [10] and Jia et al. [11] developed methods based on gas chromatography with flame-ionization detection and headspace solidphase microextraction coupled with gas chromatography-mass spectrometry to analyze the volatile constituents and raw materials of an LHQW capsule, respectively. Jia et al. [12] developed a method based on a combination of UPLC with a diode-array detector and quadrupole time-of-flight mass spectrometry to determine the major chemical constituents of an LHQW capsule. Nevertheless, a detailed analysis of the chemical composition of an LHQW capsule has not yet been reported. Orbitrap mass spectrometry (MS) has become a powerful tool to characterize the chemical components in TCMs because of its high sensitivity, high mass resolution, and high mass accuracy [13, 14] . This method also helps analyze MS n fragments, thus facilitating the structural elucidation of a compound. Gas chromatography-mass spectrometry (GC-MS) has been widely applied for the detection of volatile components in a TCM [15] . In this paper, we present the unprecedented comprehensive analysis of the major chemical components in an LHQW capsule by high-performance liquid chromatography (HPLC)-Q Exactive-Orbitrap-MS coupled with GC-MS. In total, 104 compounds including 6 alkaloids, 33 flavonoids, 7 phenols, 9 phenolic acids, 16 phenylpropanoids, 7 quinones, 12 terpenoids and 14 other phytochemicals, were putatively identified via HPLC-Q Exactive-Orbitrap-MS. In addition, 17 volatile compounds were putatively identified via GC-MS. Thus, a total of 120 compounds were successfully extracted and characterized. LHQW capsules (Lot No. B2001158) were obtained from Yiling Pharmaceutical Co., Ltd. (Shijiazhuang, China). Acetonitrile (ACN, HPLC grade) and methanol (HPLC grade) were obtained from Merck KGaA (Darmstadt, Germany). Watsons-distilled water was purchased from Jingdong Mall (Beijing, China). Formic acid (FA), acetone (HPLC grade), and hexane (HPLC grade) were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Ethyl acetate was purchased from Sigma-Aldrich (St. Louis, MO, USA). For the HPLC-Q Exactive-Orbitrap-MS analysis, the raw material (brown powder; 0.4 g) of the LHQW capsule was accurately weighed, dissolved in 60% methanol (V/V; 20 mL), and sonicated for 30 min. The solution was centrifuged at 12,000 r/min and the supernatant was filtered through a 0.22 mm membrane. For GC-MS analysis, three different extraction solvents were used: hexane, acetone, and ethyl acetate. The raw material (1 g) was accurately weighed, dissolved in the extracted solvent (10 mL), and sonicated for 20 min. The resulting extracts were centrifuged at 12,000 r/min and the supernatants were analyzed. An HPLC-high resolution mass spectrometer (HPLC-HRMS; Ultimate 3000 HPLC system, Thermo Fisher Scientific, Waltham, MA, USA) equipped with a reversed-phase Hypersil Gold aQ C 18 column (2.1 mm  150 mm, 3 mm; Thermo Fisher Scientific, Waltham, MA, USA) was used to determine the chemical constituents present in the LHQW sample. The column temperature was maintained at 40 C. The mobile phases included 0.1% FA in ACN (A) and 0.1% FA in H 2 O (B). A constant flow rate was maintained (0.2 mL/min). The elution gradient was maintained at 5% A for 1 min, increased to 95% A over 41 min, and maintained at this phase for 4.9 min. The column was then re-equilibrated at 5% A for 3 min. The samples were maintained at room temperature and the injection volume was 5 mL. The Q Exactive mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a heated electrospray ionization interface was operated under both electrospray ionization (ESI) negative and ESI positive modes. The instrument was calibrated with the calibration solutions provided by the manufacturer. Data were acquired using Xcalibur 4.1 software (Thermo Fisher Scientific, Waltham, MA, USA), and all obtained data were processed by the Compound Discoverer (CD) 3.0 (Thermo Fisher Scientific, Waltham, MA, USA) and Xcalibur 4.1 software packages. The source parameters were optimized with a spray voltage of 3.5 kV (þ)/3.2 kV (À). The other parameters were set as follows: capillary temperature, 320 C; auxiliary gas heater temperature, 350 C; sheath gas pressure, 40 arb; auxiliary gas pressure, 15 arb; sweep gas pressure, 0 arb; S-lens RF level, 50 V. The Q Exactive detector was operated in full scan and datadependent MS 2 (dd MS 2 ) modes. In full scan mode, the resolution was set at 70,000. The automatic gain control (AGC) target and maximum injection time (IT) were 1  10 6 ions capacity and 100 ms, respectively. For the dd MS 2 mode, the acquisition parameters were: resolution, 17,500; AGC target, 2  10 5 ions capacity; maximum IT, 50 ms; scan range, 100e1500 m/z; loop count, 3; normalized collision energy (stepped), 20%, 40%, 60%; isolation window, 1.2 Da; apex trigger, 5e15 s; dynamic exclusion, 5 s. The Top N (N ¼ number of top abundant ions for fragmentation) was set to 5. The GC-MS analysis was conducted on a Trace GC Ultra system equipped with an AS 3000 auto-sampler, a split/splitless injector, and TSQ Quantum XLS MS detector with triple quadrupole (Thermo Fisher Scientific, Waltham, MA, USA). The TR-5 MS capillary column (30 m  0.25 mm, 0.25 mm film thickness) was purchased from Thermo Fisher Scientific (Waltham, MA, USA). The injection temperature and ion source temperature were 250 C. The oven temperature program was maintained at 50 C for 1 min, increased to 200 C (rate: 8 C/min), maintained at 200 C for 5 min, increased to 280 C (rate: 10 C/min), and maintained for 5 min. Helium was used as the carrier gas (flow rate: 1 mL/min). Sample injection volume and split ratio were 1 mL and 50:1, respectively. The ionizing energy was 70 eV. The chromatograms were obtained by collecting the total ion currents in the scan range of m/z 50e550. Data were acquired using the Xcalibur 2.2 software. The raw data acquired from the HPLC-Q Exactive-Orbitrap-MS analysis were processed by the CD 3.0 software. The data matrices of the molecular masses, retention time, fragments, and peak areas from both ESI positive and negative modes were extracted and aligned to the mzVault library, which was integrated in the CD software. The mzVault spectral library (Thermo Fisher Scientific, Waltham, MA, USA) contained the retention time, precise mass ions, and MS 2 fragments of 1200 commercial reference standards, which were analyzed by Q Exactive-Orbitrap-MS. The CD software equipped with the mzVault library identified peaks with a high mass accuracy (< 5 ppm) and an isotope pattern variation within 85%. The molecular compositions adhered to the hydrogen to carbon ratio rules, and were matched to potential compounds using rings and double-bonds equivalents. The MS 2 spectra were compared with the reference spectra from the mzVault library. Compound identification was accepted only when the matching score was greater than 85 (total score ¼ 100). In addition, the accuracy of the compound identification was improved by comparing the obtained data and possible fragmentation patterns with those reported in the literature. The base peak chromatograms of the LHQW capsule in positive and negative ion modes are depicted in Fig. 1 . In total, 104 compounds, including alkaloids, flavonoids, phenols, phenolic acids, phenylpropanoids, quinones, terpenoids, and other phytochemicals, were putatively identified (as listed in Table 1 [16e44]) using the library alignment method. According to previous studies [16e44], the identified compounds are present in the herbs used in the LHQW formulation. No phytochemical was identified from Dryopteridis Crassirhizomatis Rhizoma. The compound identification of several specific compounds is presented below. The molecular formula of compound 71 was C 16 H 14 O 5 , as established by the [MÀH]peak at m/z 285.0760. The MS 2 spectrum was similar to that previously reported [31] for licochalcone B. The MS 2 spectrum and the possible fragmentation pathway are shown in Fig. S1A . The peak at m/z 270.0530 indicates the formation of [MeHeCH 3 ] -. The base peak at m/z 150.0316 is attributed to the fragment generated by the cleavage of groups around the carbonyl carbon, followed by loss of CH 3 unit. The fragment responsible for the peak at m/z 177.0189 is shown in Fig. S1A . The mzVault library alignment results ( Fig. S1B ; score: 89.9) revealed that the compound was licochalcone B, which is a phytochemical present in Glycyrrhizae Radix Et Rhizoma. The molecular formula of compound 26 was C 16 OeCO] þ (m/z 151.0755). The base peak at m/z 127.0392 is attributed to the fragment that was generated by the retro-Diels-Alder fragmentation, as shown in Fig. S2A . The library alignment ( Fig. S2B ; score: 96.2) and comparison with literature data [24] revealed that compound 26 was sweroside, a phytochemical present in Lonicerae Japonicae Flos. The molecular formula of compound 97 was C 15 [42] revealed that the compound was emodin, a constituent of Rhei Radix Et Rhizoma. Compound 31 had a molecular formula of C 9 H 10 O 5 , as evaluated from the molecular ion peak at m/z 197.0451 ([MÀH] -) in the MS 2 spectrum (Fig. S4A) The peak at m/z 579.2079 in the MS spectrum of compound 75 is attributed to the [MþHCOO]adduct, while the peak at m/z 533.2019 corresponds to [MÀH] -. Characteristic peaks were m/z 371.1490, 356.1250, and 121.0288 in the MS 2 spectrum. Library alignment (Fig. S5B ) and a comparison with literature data [29] revealed that compound 75 was forsythin, a phytochemical present in Forsythiae Fructus. The possible fragmentation pathways and the characteristic fragments are shown in Fig. S5A . The peak at m/z 299.1133 in the MS 2 spectrum of compound 17 is attributed to the [MÀH]ion. Some characteristic peaks and the corresponding fragments were at m/z 137.0605 ([MeHeGlc] -) and m/z 119.0496 ([MeHeGlceH 2 O] -), and the data are in accordance with that of previous studies [25] . The possible fragmentation pathway is shown in Fig. S6A. Library alignment (Fig. S6B ; score: 96.6) identified the compound as salidroside, a compound derived from Rhodiolae Crenulatae Radix Et Rhizoma. The molecular formula of compound 7 was C 5 H 5 N 5 . There were only two characteristic peaks in the MS 2 spectrum (Fig. S7A) : m/z Fig. S8A . Comparison of the possible fragmentation pathway with reference data [27, 28] , along with the library alignment (Fig. S8B ) of the retention time in ESI(À) mode indicated that compound 22 was amygdalin, a chemical constituent present in Armeniacae Semen Amarum. The volatile constituents in the LHQW capsule were extracted in three different solvents, i.e., hexane, acetone, and ethyl acetate, and then detected using GC-MS. The total ion chromatograms (TICs; Fig. S9 ) of all three extracts were similar. The TIC of the LHQW capsule extracted in ethyl acetate is shown in Fig. 2 . In total, 17 volatile compounds (Table 2) [43, 45e48] were putatively identified by comparing the obtained data with that from the NIST mass spectra library and previously reported literature [11] . The results showed that the major constituent was levomenthol with a relative percentage of 97.89%, as calculated by the peak area normalization method. The other most abundant components were patchouli alcohol (0.47%), b-pathchoulene (0.33%), a-guaiene (0.22%), and a-bulnesene (0.20%). Patchouli alcohol has anti-virus and anti-inflammatory activities reported by Kiyohara et al. [49] . Most of the components were terpenoids derived from Menthae Haplocalycis Herba and Pogostemonis Herba. In this study, HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS method was used for the first time to identify the chemical constituents in the LHQW capsule, a popular TCM prescribed to treat the symptoms of SARS-CoV-2 infections. In addition, the MS and MS 2 spectrum library alignment method was found to be a convenient approach to rapidly identifying the components of a complex mixture. A total of 120 constituents, including alkaloids, flavonoids, phenols, phenolic acids, phenylpropanoids, quinones, terpenoids, and other phytochemicals, were successfully detected and putatively identified in this study. The findings of our study can contribute to future investigations on the active chemical constituents and the mechanism of action of the LHQW capsule. The authors declare that there are no conflicts of interest. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial Lianhuaqingwen exerts anti-viral and antiinflammatory activity against novel coronavirus (SARS-CoV-2) Comilation prepared by National Health Commission of the People's Republic of China Rapid determination of ingredients in water extraction of Lianhua Qingwen capsule by UPLC Study on UPLC fingerprints of Lianhua Qingwen capsules Contents determination of methol in lianhuaqingwen capsule by gas chromatography Determining volatiles from raw materials of Lianhua Qingwen preparations by HS-SPME-GC/MS Qualitative and quantitative analysis of the major constituents in Chinese medical preparation Lianhua-Qingwen capsule by UPLC-DAD-QTOF-MS An integrated strategy based on characteristic fragment filter supplemented by multivariate statistical analysis in multistage mass spectrometry chromatograms for the large-scale detection and identification of natural plant-derived components in rat: the rhubarb case UHPLC Q-Exactive MS-based spleen metabolomics and lipidomics to explore the effect mechanisms of Danggui Buxue Decoction in anemia mice An integration of UPLC-DAD/ESI-Q-TOF MS, GC-MS, and PCA analysis for quality evaluation and identification of cultivars of Chrysanthemi Flos (Juhua) Chemical constituents from water extract of Radix isatidis Traditional Chinese medicine systems pharmacology database and analysis platform, Compilation prepared by center for bioinformatics Comparison of multiple bioactive constituents in the flower and the caulis of Lonicera japonica based on UFLC-QTRAP-MS/MS combined with multivariate statistical analysis Chemical constituents and pharmacological effects of houttuynia cordata Quantitative and chemical fingerprint analysis for the quality evaluation of Isatis indigotica based on ultra-performance liquid chromatography with photodiode array detector combined with chemometric methods Determination of nucleosides and nucleobases in isatidis Radix by Fast profiling of chemical constituents in Yiqing Capsule by ultra-performance liquid chromatography coupled to electrospray ionization tandem mass spectrometry In vitro antioxidant and anti-inflammatory activities of Radix Isatidis extract and bioaccessibility of six bioactive compounds after simulated gastro-intestinal digestion Structural characterization and identification of iridoid glycosides, saponins, phenolic acids and flavonoids in Flos Lonicerae Japonicae by a fast liquid chromatography method with diode-array detection and timeof-flight mass spectrometry Characterization of the chemical constituents in Hongjingtian injection by liquid chromatography quadrupole time-of-flight mass spectrometry Differences in chemical component and anticancer activity of green and ripe Forsythiae Fructus Identification of chemical constituents and rat metabolites of Kangxianling granule by Identification and analysis of amygdalin, neoamygdalin and amygdalin amide in different processed bitter almonds by Pharmacokinetics screening for multicomponents absorbed in the rat plasma after oral administration of traditional Chinese medicine Flos Lonicerae Japonicae-Fructus Forsythiae herb couple by sequential negative and positive ionization ultra-high-performance liquid chromatography/tandem triple quadrupole mass spectrometric detection Characterization of phenolic compounds in the fruits of Forsythia suspensa by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry An integrated exact mass spectrometric strategy for comprehensive and rapid characterization of phenolic compounds in licorice Antiradical and anti-H 2 O 2 properties of polyphenolic compounds from an aqueous peppermint extract Determination of markers from characteristic HPLC chromatogram of phenols in three official origins of Ephedrae Herba and quantitative analysis of four phenols Determination and quality analysis of two flavonoids in houttuynia cordata thunb. From different sources, Mod Analysis of non-volatile chemical constituents of Menthae Haplocalycis Herba by ultra-high performance liquid chromatography-high resolution mass spectrometry Isolation, structural elucidation and in vitro hepatoprotective activity of flavonoids from Glycyrrhiza uralensis Chemical constituents from root of Isatis indigotica The phenolic fraction of mentha haplocalyx and its constituent linarin ameliorate inflammatory response through inactivation of NF-kappaB and MAPKs in lipopolysaccharide-induced RAW264.7 cells Characterization of Nine Compounds Isolated from the Acid Hydrolysate of Lonicera fulvotomentosa Hsu et S. C. Cheng and Evaluation of Their In Vitro Activity towards HIV Protease Determination of oleanolic acid and ursolic acid in pogostemon cablin by HPLC Rapid characterization of chemical constituents and rat metabolites of Fufang Gancao Tablets by UHPLC-LTQ-Orbitrap mass spectrometer Global chemical profiling based quality evaluation approach of rhubarb using ultra performance liquid chromatography with tandem quadrupole time-of-flight mass spectrometry Preparative isolation and purification of five flavonoids from pogostemon cablin benth by high-speed countercurrent chromatography and preparative high-performance liquid chromatography Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata Relativity of commercial specification of Menthae Herba based on chemical analysis Optimization for decocting later of Menthae Herba in Eungyo-San, a herbal formula, using response surface methodology with gas chromatography/mass spectrometry Evaluation of the larvicidal potential of the essential oil pogostemon cablin (blanco) benth in the control of Aedes aegypti Full-length transcriptome sequencing and methyl jasmonate-induced expression profile analysis of genes related to patchoulol biosynthesis and regulation in Pogostemon cablin Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth This work is financially supported by the Fundamental Research Funds for the Central Universities (Grant No.: 2042020kf1003). Supplementary data to this article can be found online at https://doi.org/10.1016/j.jpha.2021.01.004.